GlassScriptPhysician profile
David A Engorn
NPI 1942645270
$28,934.19
in general payments reported to CMS, 2019-2025
43 companies · $1,877 in 2025
The $1,877 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,793 · 2020: $4,040 · 2021: $5,183 · 2022: $7,099 · 2023: $3,657 · 2024: $2,285 · 2025: $1,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,599 · Food and Beverage: $3,413 · Consulting Fee: $500 · Long Term Medical Supply Or Device Loan: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,599.21 |
| Food and Beverage | $3,413.38 |
| Consulting Fee | $500.00 |
| Long Term Medical Supply Or Device Loan | $306.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,434.83 | 2019-2023 | |
| Supreme Orthopedic Systems, LLC | $4,831.16 | 2019-2025 | |
| Stryker Corporation | $4,392.81 | 2019-2025 | Prostep, Prophecy, Iconix |
| Goode Surgical INC | $2,486.09 | 2021-2022 | |
| Paragon 28, INC. | $1,736.75 | 2022-2025 | Bun-Yo-Matic |
| Treace Medical Concepts, INC. | $999.63 | 2021-2024 | |
| Convatec INC. | $562.16 | 2023 | |
| Integra Lifesciences Corporation | $551.45 | 2019-2025 | Integra, Acell, Primatrix |
| Intelivation Technologies, LLC | $500.00 | 2025 | |
| Acumed LLC | $421.77 | 2022-2024 | Osteomed, Acumed |
| Horizon Therapeutics Plc | $373.25 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $192.65 | 2019-2024 | Evos, Stravix Pl, Grafix Pl |
| Mimedx Group, INC. | $155.36 | 2024-2025 | |
| Avanos Medical | $146.01 | 2025 | On-Q Pump and Accessories |
| Linvatec Corporation | $137.64 | 2025 | Biobrace 23mm, Allograft Tissue, Neospan |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $94.50 | 2022 | |
| Flower Orthopedics Coporation | $94.25 | 2023 | |
| Crossroads Extremity Systems, LLC | $76.08 | 2020 | |
| Arteriocyte Medical Systems, INC. | $73.75 | 2019 | |
| Bioventus LLC | $59.33 | 2019-2021 | |
| Abbvie INC. | $56.26 | 2021 | |
| Nevro Corp. | $53.72 | 2021-2023 | Senza |
| Zimmer Biomet Holdings, INC. | $51.54 | 2021-2024 | Stratum Foot Plating System |
| Biocomposites INC | $49.51 | 2019-2025 | Stimulan |
| Depuy Synthes Sales INC. | $37.93 | 2025 | Orthovisc |
| Kerecis Limited | $37.00 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Pacira Pharmaceuticals Incorporated | $32.90 | 2023-2024 | Iovera, Zilretta, Exparel |
| Osteomed LLC | $32.35 | 2019-2020 | |
| Ethicon US, LLC | $26.07 | 2024 | Ethicon, Stratafix |
| Anika Therapeutics, INC. | $25.96 | 2022 | |
| Heron Therapeutics, INC. | $21.44 | 2021 | |
| Osiris Therapeutics INC. | $20.63 | 2019 | |
| Triad Life Sciences INC. | $20.34 | 2022 | |
| Acera Surgical, INC. | $18.85 | 2021 | |
| Amgen INC. | $16.83 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.36 | 2020 | |
| Orthofix Medical, INC. | $15.82 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $14.47 | 2023 | Acuson Juniper Diagnostic Ultrasound System |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Organogenesis INC. | $13.78 | 2020 | |
| Alfasigma USA, INC. | $13.76 | 2021 | |
| Axogen | $13.28 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Assertio Therapeutics, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Engorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.